Fractional volume of placental vessels in women with diabetes using a novel stereological 3D power Doppler technique

In maternal diabetes the placenta is large with abnormal vascular development and increased villous volume. We used a novel stereological 3D power Doppler ultrasound technique to investigate differences in-vivo in the placental fractional volume of power Doppler signal (FrVol-PD) between women with...

Full description

Saved in:
Bibliographic Details
Published inPlacenta (Eastbourne) Vol. 34; no. 11; pp. 1002 - 1008
Main Authors Jones, N.W., Deshpande, R., Mousa, H.A., Mansell, P., Raine-Fenning, N., Bugg, G.
Format Journal Article
LanguageEnglish
Published Kidlington Elsevier Ltd 01.11.2013
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:In maternal diabetes the placenta is large with abnormal vascular development and increased villous volume. We used a novel stereological 3D power Doppler ultrasound technique to investigate differences in-vivo in the placental fractional volume of power Doppler signal (FrVol-PD) between women with and without diabetes. We recruited 17 pregnant women with pre-gestational diabetes and 20 controls, all with anterior placentae. Each subject had ultrasound scans (Voluson 730 Expert) every 4 weeks between 12 and 32 weeks gestation. 3D power Doppler data were acquired and the placenta manually outlined using VOCAL (4D View). Power Doppler signal within the resultant volume was counted in a 3D manner adapting the random but systematic techniques used in stereology. Subjects were of similar age, BMI and parity. From 16 weeks the mean (SD) placental FrVol-PD was higher in the non-diabetic than in the diabetic group: 16 weeks – 0.125 (0.03) versus 0.108 (0.03), 20 weeks – 0.144 (0.05) versus 0.104 (0.03), 24 weeks – 0.145 (0.05) versus 0.128 (0.03), 28 weeks – 0.159 (0.05) versus 0.133 (0.02) and 32 weeks – 0.154 (0.03) versus 0.123 (0.04). These differences were significant between control and diabetic subjects [F(1,35) = 4.737, p = 0.036] and across gestation [F(3,140) = 8.294, p < 0.001]. Using a novel stereological-based ultrasound technique we have demonstrated the reliability of this application in the placenta. This technique shows promise for non-invasive assessment of placental function: further studies are required to identify if structural changes in a diabetic placenta are accompanied by altered function, manifest as reduced perfusion demonstrable in-vivo.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
ISSN:0143-4004
1532-3102
1532-3102
DOI:10.1016/j.placenta.2013.08.015